Tefazoline
- Level
- Commodity
- Parent
- 51392200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51392213This classification denotes an alpha-adrenergic agonist with the molecular formula C14H18N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9738II2CCH, chemically known as 2-(5,6,7,8-tetrahydro-1-naphthyl)methyl)-2-imidazolin but generally known as tefazoline, which bears US NIH Compound Identifier 163309. European Medicines Agency schedules Tefazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10865MIG. The term TEFAZOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). TEFAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tefazoline under HS 29332990 and SITC 51573. As of Q4 2014, TEFAZOLINE remains the US FDA Preferred Term for this commodity. Tefazoline bears US NLM identifiers UMLS ID C2699906 and NCI Concept Code C75044. SMILES: N1C(=NCC1)CC1C2CCCCC2CCC1.
Same parent
Under 51392200 · 30Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.